Fate Therapeutics (FATE) Competitor Comparison
We are evaluating the key criteria listed to compare Fate Therapeutics (FATE) against its competitors in the Biotechnology industry.
Market Capitalization
145 / 368Gross Profits
264 / 278Total Revenue
87 / 300EBITDA
278 / 337Free Cashflow
293 / 352Quick Ratio
99 / 357Earnings per Share
179 / 359Dividend yield
0 / 6Total Cash
91 / 358Performance 3 years
344 / 368Performance 5 years
257 / 368Performance 10 years
145 / 368Linearity 3 years
283 / 368Linearity 5 years
68 / 368Linearity 10 years
12 / 368Total Rank
124 / 368Dividend Rank
127 / 368Valuation Rank
289 / 368Piotroski Rank
279 / 368Muliplier Rank
99 / 368Performance 3 years - FATE ranking 344 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.